Quest Diagnostics Live Stock Price Today, Share Analysis and Chart

Name: Quest Diagnostics, Inc.: Is Infosys Ltd. worth buying?
Item: Quest Diagnostics, Inc.
Rating: 2.350777625
Author: Trendlyne DVM scores

Turnaround Potential

about

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing ...

192.20 -2.70 (-1.39%)

609.5K

XNYS Volume

XNYS 01 Jun, 2026 5:30 PM (EDT)

Dividend

Quest Diagnostics has an upcoming dividend of $0.860 per share due on 08 Jul 2026 See details

Medium Financial Strength

44.4 / 100

Mid Valuation

37.3 / 100

Technically Moderately Bullish

61.8 / 100

Turnaround Potential These stocks have average financials and valuation, but strong momentum indicating buying interest View Similar Embed DVM

223

1Yr Price target upside is 16%

16 analysts

Quest Diagnostics Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Quest Diagnostics Live Stock Price Today, Share Analysis and Chart

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing ...

SWOT Analysis

Quest Diagnostics Live Price Chart